Neuroimaging Considerations in Patients with Chronic Kidney Disease

Neurological complications of chronic kidney disease.

Nat Rev Neurol. 5: 542-551

The nature, consequences, and management of neurological disorders in chronic kidney disease.

Hemodial Int. 22: 150-160Levy EM Viscoli CM Horwitz RI.

The effect of acute renal failure on mortality. A cohort analysis.

JAMA. 275: 1489-1494Major RW Cheng MRI Grant RA Shantikumar S Xu G Oozeerally I et al.

Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis.

PLoS One. 13e0192895Arnold R Issar T Krishnan AV Pussell BA.

Neurological complications in chronic kidney disease.

JRSM Cardiovasc Dis. 52048004016677687Assem M Lando M Grissi M Kamel S Massy ZA Chillon JM et al.

The impact of uremic toxins on cerebrovascular and cognitive disorders.

Toxins (Basel). 10Lourida I Thompson-Coon J Dickens CM Soni M Kuzma E Kos K et al.

Parathyroid hormone, cognitive function and dementia: a systematic review.

PLoS One. 10e0127574Sweeney MD Kisler K Montagne A Toga AW Zlokovic BV.

The role of brain vasculature in neurodegenerative disorders.

Nat Neurosci. 21: 1318-1331Goyal M Menon BK van Zwam WH Dippel DW Mitchell PJ Demchuk AM et al.

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.

Lancet. 387: 1723-1731Nogueira RG Jadhav AP Haussen DC Bonafe A Budzik RF Bhuva P et al.

Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct.

N Engl J Med. 378: 11-21Albers GW Marks MP Kemp S Christensen S Tsai JP Ortega-Gutierrez S et al.

Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging.

N Engl J Med. 378: 708-718Medina-Rodriguez M Millan-Vazquez M Zapata-Arriaza E Escudero I Pardo-Galiana B Cabezas-Rodriguez JA et al.

Intravenous thrombolysis guided by perfusion ct with alteplase in >4.5 hours from stroke onset.

Cerebrovasc Dis. 49: 328-333Ma H Campbell BCV Parsons MW Churilov L Levi CR Hsu C et al.

Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke.

N Engl J Med. 380: 1795-1803Marsh EB Llinas RH Hillis AE Gottesman RF.

Hemorrhagic transformation in patients with acute ischaemic stroke and an indication for anticoagulation.

Eur J Neurol. 20: 962-967

Renal dysfunction and thrombolytic therapy in patients with acute ischemic stroke: a systematic review and meta-analysis.

Medicine (Baltimore). 93: e286Kim JK Shin JJ Park SK Hwang YS Kim TH Shin HS.

Prognostic factors and clinical outcomes of acute intracerebral hemorrhage in patients with chronic kidney disease.

J Korean Neurosurg Soc. 54: 296-301Wada R Aviv RI Fox AJ Sahlas DJ Gladstone DJ Tomlinson G et al.

Ct angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage.

Stroke. 38: 1257-1262Vedicherla SV Foo AS Sharma VK Ting EY Sein L Chou N et al.

The “blush” sign on computed tomography angiography is an independent predictor of hematoma progression in primary hypertensive hemorrhage.

J Stroke Cerebrovasc Dis. 27: 1878-1884Ng D Churilov L Mitchell P Dowling R Yan B.

The CT swirl sign is associated with hematoma expansion in intracerebral hemorrhage.

AJNR Am J Neuroradiol. 39: 232-237Li Q Liu QJ Yang WS Wang XC Zhao LB Xiong X et al.

Island sign: an imaging predictor for early hematoma expansion and poor outcome in patients with intracerebral hemorrhage.

Stroke. 48: 3019-3025Ikram MA Vernooij MW Hofman A Niessen WJ van der Lugt A Breteler MM.

Kidney function is related to cerebral small vessel disease.

Stroke. 39: 55-61Ovbiagele B Wing JJ Menon RS Burgess RE Gibbons MC Sobotka I et al.

Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage.

Stroke. 44: 2409-2413Yeh YC Kuo YT Huang MF Hwang SJ Tsai JC Kuo MC et al.

Association of brain white matter lesions and atrophy with cognitive function in chronic kidney disease.

Int J Geriatr Psychiatry. 34: 1826-1832

Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.

Lancet Neurol. 14: 914-925Lamy C Oppenheim C Meder JF Mas JL.

Neuroimaging in posterior reversible encephalopathy syndrome.

J Neuroimaging. 14: 89-96Covarrubias DJ Luetmer PH Campeau NG.

Posterior reversible encephalopathy syndrome: Prognostic utility of quantitative diffusion-weighted MR images.

AJNR Am J Neuroradiol. 23: 1038-1048Ray S Howlader S Chakraborty S Chakraborty PP Ghosh S.

Hemichorea-hemiballism as the first presentation of type 2 diabetes.

Clin Diabetes. 33: 87-89Nath J Jambhekar K Rao C Armitano E.

Radiological and pathological changes in hemiballism-hemichorea with striatal hyperintensity.

J Magn Reson Imaging. 23: 564-568Bizet J Cooper CJ Quansah R Rodriguez E Teleb M Hernandez GT.

Chorea, hyperglycemia, basal ganglia syndrome (c-h-bg) in an uncontrolled diabetic patient with normal glucose levels on presentation.

Am J Case Rep. 15: 143-146da Silva CJ da Rocha AJ Jeronymo S Mendes MF Milani FT Maia Jr., AC et al.

A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: manganism symptoms and t1 hyperintense changes in the basal ganglia.

AJNR Am J Neuroradiol. 28: 1474-1479

Uremic encephalopathy and other brain disorders associated with renal failure.

Semin Neurol. 31: 139-143Grasso D Borreggine C Perfetto F Bertozzi V Trivisano M Specchio LM et al.

Lentiform fork sign: a magnetic resonance finding in a case of acute metabolic acidosis.

Neuroradiol J. 27: 288-292

Uremic encephalopathy: Mr imaging findings and clinical correlation.

AJNR Am J Neuroradiol. 37: 1604-1609Tarhan NC Agildere AM Benli US Ozdemir FN Aytekin C Can U.

Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: Mri of the brain.

AJR Am J Roentgenol. 182: 809-816

Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes.

J Neurol Neurosurg Psychiatry. 75 (): iii22-iii28Graff-Radford J Fugate JE Kaufmann TJ Mandrekar JN Rabinstein AA.

Clinical and radiologic correlations of central pontine myelinolysis syndrome.

Mayo Clin Proc. 86: 1063-1067Patel N Dalal P Panesar M.

Dialysis disequilibrium syndrome: a narrative review.

Semin Dial. 21: 493-498Chen CL Lai PH Chou KJ Lee PT Chung HM Fang HC.

A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted mr imaging.

AJNR Am J Neuroradiol. 28: 68-71Bugnicourt JM Godefroy O Chillon JM Choukroun G Massy ZA.

Cognitive disorders and dementia in CKD: the neglected kidney-brain axis.

J Am Soc Nephrol. 24: 353-363Vermeer SE Prins ND den Heijer T Hofman A Koudstaal PJ Breteler MM.

Silent brain infarcts and the risk of dementia and cognitive decline.

N Engl J Med. 348: 1215-1222

Brain atrophy and cognitive impairment in chronic kidney disease.

Contrib Nephrol. 196: 27-36Tsuruya K Yoshida H Kuroki Y Nagata M Mizumasa T Mitsuiki K et al.

Brain atrophy in peritoneal dialysis and ckd stages 3-5: a cross-sectional and longitudinal study.

Am J Kidney Dis. 65: 312-321Drew DA Koo BB Bhadelia R Weiner DE Duncan S la Garza MM et al.

White matter damage in maintenance hemodialysis patients: a diffusion tensor imaging study.

BMC Nephrol. 18: 213

Kdigo clinical practice guidelines for acute kidney injury.

Nephron Clin Pract. 120: c179-c184van der Molen AJ Reimer P Dekkers IA Bongartz G Bellin MF Bertolotto M et al.

Post-contrast acute kidney injury - part 1: definition, clinical features, incidence, role of contrast medium and risk factors : recommendations for updated esur contrast medium safety committee guidelines.

Eur Radiol. 28: 2845-2855Murphy SW Barrett BJ Parfrey PS

Contrast nephropathy.

J Am Soc Nephrol. 11: 177-182

Contrast-medium-induced acute renal failure.

Kidney Int. 53: 230-242Geenen RW Kingma HJ van der Molen AJ.

Contrast-induced nephropathy: pharmacology, pathophysiology and prevention.

Insights Imaging. 4: 811-820

Contrast medium-induced nephrotoxicity: which pathway?.

Radiology. 235: 752-755Heyman SN Rosen S Khamaisi M Idee JM Rosenberger C.

Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy.

Invest Radiol. 45: 188-195Aycock RD Westafer LM Boxen JL Majlesi N Schoenfeld EM Bannuru RR.

Acute kidney injury after computed tomography: a meta-analysis.

Ann Emerg Med. 71 (): 44-53McDonald RJ McDonald JS Bida JP Carter RE Fleming CJ Misra S et al.

Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?.

Radiology. 267: 106-118Davenport MS Khalatbari S Cohan RH Dillman JR Myles JD Ellis JH.

Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: Risk stratification by using estimated glomerular filtration rate.

Radiology. 268: 719-728Chaudhury P Armanyous S Harb SC Ferreira Provenzano L Ashour T Jolly SE et al.

Intra-arterial versus intravenous contrast and renal injury in chronic kidney disease: a propensity-matched analysis.

Nephron. 141: 31-40Wichmann JL Katzberg RW Litwin SE Zwerner PL De Cecco CN Vogl TJ et al.

Contrast-induced nephropathy.

Circulation. 132: 1931-1936Kooiman J Pasha SM Zondag W Sijpkens YW van der Molen AJ Huisman MV et al.

Meta-analysis: Serum creatinine changes following contrast enhanced ct imaging.

Eur J Radiol. 81: 2554-2561

Contrast-induced nephropathy: what are the true clinical consequences?.

Clin J Am Soc Nephrol. 3: 263-272Mardani S Nasri P Tavakoli M.

Contrast induced nephropathy; recent findings.

J Nephropharmacol. 2: 27-30Brinjikji W Demchuk AM Murad MH Rabinstein AA McDonald RJ McDonald JS et al.

Neurons over nephrons: systematic review and meta-analysis of contrast-induced nephropathy in patients with acute stroke.

Stroke. 48: 1862-1868Moos SI van Vemde DN Stoker J Bipat S.

Contrast induced nephropathy in patients undergoing intravenous (iv) contrast enhanced computed tomography (cect) and the relationship with risk factors: a meta-analysis.

Eur J Radiol. 82: e387-e399

Radiology ACo. Manuel on contrast media. 2020

Davenport MS Khalatbari S Cohan RH Ellis JH.

Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level- and estimated glomerular filtration rate-based screening methods.

Radiology. 269: 92-100

Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.

Radiology. 188: 171-178Merten GJ Burgess WP Gray LV Holleman JH Roush TS Kowalchuk GJ et al.

Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial.

JAMA. 291: 2328-2334Navaneethan SD Singh S Appasamy S Wing RE Sehgal AR.

Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Am J Kidney Dis. 53: 617-627Gonzales DA Norsworthy KJ Kern SJ Banks S Sieving PC Star RA et al.

A meta-analysis of n-acetylcysteine in contrast-induced nephrotoxicity: Unsupervised clustering to resolve heterogeneity.

BMC Med. 5: 32Marenzi G Assanelli E Marana I Lauri G Campodonico J Grazi M et al.

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

N Engl J Med. 354: 2773-2782

Diabetes mellitus and the nervous system.

J Neurol Neurosurg Psychiatry. 65: 620-632Baerlocher MO Asch M Myers A.

Five things to know about. Metformin and intravenous contrast.

CMAJ. 185: E78Goergen SK Rumbold G Compton G Harris C.

Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.

Radiology. 254: 261-269

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.

Biometals. 29: 365-376Smith TE Steven A Bagert BA.

Gadolinium deposition in neurology clinical practice.

Ochsner J. 19: 17-25Attari H Cao Y Elmholdt TR Zhao Y Prince MR.

A systematic review of 639 patients with biopsy-confirmed nephrogenic systemic fibrosis.

Radiology. 292: 376-386Daram SR Cortese CM Bastani B.

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: Report of a new case with literature review.

Am J Kidney Dis. 46: 754-759Gibson SE Farver CF Prayson RA.

Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature.

Arch Pathol Lab Med. 130: 209-212Shabana WM Cohan RH Ellis JH Hussain HK Francis IR Su LD et al.

Nephrogenic systemic fibrosis: A report of 29 cases.

AJR Am J Roentgenol. 190: 736-741Weinreb JC Rodby RA Yee J Wang CL Fine D McDonald RJ et al.

Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the american college of radiology and the national kidney foundation.

Radiology. 298: 28-35

留言 (0)

沒有登入
gif